Synthesis of novel benzofuran-4,7-quinones from 4,6-dimethoxybenzofurans specifically targeting breast and lung cancer cells
dc.contributor.author | Ucar, Tugce N. Uslu | |
dc.contributor.author | Izgi, Samet | |
dc.contributor.author | Demir, Elif Ayazoglu | |
dc.contributor.author | Uzuner, Selcen Celik | |
dc.contributor.author | Sengul, Ibrahim F. | |
dc.contributor.author | Uzuner, Ugur | |
dc.contributor.author | Kandemir, Hakan | |
dc.date.accessioned | 2025-04-06T12:23:56Z | |
dc.date.available | 2025-04-06T12:23:56Z | |
dc.date.issued | 2025 | |
dc.department | Tekirdağ Namık Kemal Üniversitesi | |
dc.description.abstract | 4,6-Dimethoxy-2-phenylbenzofurans were synthesized from the one-pot reactions of 3,5-dimethoxyphenol and a range of alpha-bromoacetophenones. The dimethoxybenzofurans were then selectively formylated at C7 using Vilsmeier-Haack method to generate 4,6-dimethoxybenzofuran-7-carbaldehydes which have been effectively converted to 6-dimethoxybenzofuran-4,7-quinones by Dakin oxidation. The cytotoxic potentials of the targeted compounds in MDA-MB-231 breast cancer and A549 lung cancer cell lines were investigated and compared to the cytotoxicity profiles of normal breast and bronchial cells. 2-Phenylbenzofurans mostly targeted lung cancer cells whereas benzofuran-7-carbaldehydes were specifically cytotoxic for metastatic breast cancer cells. The targeted benzofuran derivatives were found to be the most effective compounds for lung and breast cancer. ADME analyses showed lethal doses of all compounds excluding benzofuran-4,7-quinones are around 4000 mg/kg. | |
dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK) [122Z598]; TUBITAK | |
dc.description.sponsorship | This study was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) under Grant Number 122Z598. The authors thank TUBITAK for their support. Authors thank Prof Zuelal ATLI SEKEROGLU (Ordu University, Department of Molecular Biology and Genetics, Tuerkiye) for providing a batch of BEAS-2B cells. | |
dc.identifier.doi | 10.1007/s00706-025-03304-w | |
dc.identifier.issn | 0026-9247 | |
dc.identifier.issn | 1434-4475 | |
dc.identifier.scopus | 2-s2.0-86000732950 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.uri | https://doi.org/10.1007/s00706-025-03304-w | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/17269 | |
dc.identifier.wos | WOS:001441649400001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Springer Wien | |
dc.relation.ispartof | Monatshefte Fur Chemie | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WOS_20250406 | |
dc.subject | Heterocycles | |
dc.subject | Benzofuran | |
dc.subject | Cytotoxicity | |
dc.subject | Bioorganic chemistry | |
dc.subject | Dakin oxidation | |
dc.title | Synthesis of novel benzofuran-4,7-quinones from 4,6-dimethoxybenzofurans specifically targeting breast and lung cancer cells | |
dc.type | Article |